Molecular Mechanisms of p63-Mediated Squamous Cancer Pathogenesis.

Carcinoma, Squamous Cell / genetics Cell Adhesion Cell Lineage / genetics Cell Movement Cell Proliferation Cell Transformation, Neoplastic / genetics Epidermis / metabolism Epithelial Cells / metabolism Gene Expression Regulation, Neoplastic Head and Neck Neoplasms / genetics Humans Lung Neoplasms / genetics Signal Transduction Skin Neoplasms / genetics Transcription Factors / genetics Tumor Suppressor Proteins / genetics
epidermal homeostasis epidermal morphogenesis keratinocytes p53 family p63 squamous carcinogenesis

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
23 Jul 2019
Historique:
received: 14 06 2019
revised: 12 07 2019
accepted: 15 07 2019
entrez: 26 7 2019
pubmed: 26 7 2019
medline: 28 12 2019
Statut: epublish

Résumé

The

Identifiants

DOI: 10.3390/ijms20143590 PMID: 31340447 PMC: PMC6678256
pubmed: 31340447
pii: ijms20143590
doi: 10.3390/ijms20143590
pmc: PMC6678256
pii:
doi:

Substances chimiques

TP63 protein, human 0
Transcription Factors 0
Tumor Suppressor Proteins 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Nature. 1999 Apr 22;398(6729):708-13
pubmed: 10227293
Nature. 1999 Apr 22;398(6729):714-8
pubmed: 10227294
Protein Sci. 1999 Aug;8(8):1708-10
pubmed: 10452616
Cancer Res. 1999 Sep 1;59(17):4165-9
pubmed: 10485447
Cell. 1999 Oct 15;99(2):143-53
pubmed: 10535733
J Invest Dermatol. 1999 Dec;113(6):1099-105
pubmed: 10594758
Development. 2000 Feb;127(3):483-92
pubmed: 10631169
Nature. 2000 Mar 2;404(6773):99-103
pubmed: 10716451
J Biol Chem. 2000 Sep 22;275(38):29503-12
pubmed: 10884390
Hum Mol Genet. 2001 Feb 1;10(3):221-9
pubmed: 11159940
Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1817-22
pubmed: 11172034
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3156-61
pubmed: 11248048
Oncogene. 2001 May 31;20(25):3193-205
pubmed: 11423969
Nature. 2001 Nov 1;414(6859):105-11
pubmed: 11689955
Clin Cancer Res. 2002 Feb;8(2):494-501
pubmed: 11839669
J Biol Chem. 2002 May 24;277(21):18817-26
pubmed: 11893750
Mol Cell Biol. 2002 Dec;22(24):8601-11
pubmed: 12446779
Mol Cell Biol. 2002 Dec;22(24):8659-68
pubmed: 12446784
J Biol Chem. 2003 Jun 27;278(26):23906-14
pubmed: 12692135
Development. 2003 Nov;130(22):5493-501
pubmed: 14530295
Clin Cancer Res. 2003 Nov 15;9(15):5642-51
pubmed: 14654547
Genes Dev. 2004 Jan 15;18(2):126-31
pubmed: 14729569
Biochem Biophys Res Commun. 2004 May 7;317(3):865-72
pubmed: 15081420
Cancer Cell. 2005 Apr;7(4):363-73
pubmed: 15837625
Mol Cell Biol. 2005 Jul;25(14):6077-89
pubmed: 15988020
Genes Dev. 2005 Sep 1;19(17):1986-99
pubmed: 16107615
J Biol Chem. 2006 Feb 3;281(5):2533-42
pubmed: 16319057
J Biol Chem. 2006 Mar 24;281(12):7856-62
pubmed: 16446369
Development. 2006 Apr;133(8):1553-63
pubmed: 16524929
Cell Death Differ. 2006 Jun;13(6):1037-47
pubmed: 16601749
Genes Dev. 2006 Apr 15;20(8):1028-42
pubmed: 16618808
Nat Cell Biol. 2006 Jun;8(6):551-61
pubmed: 16715076
Eur J Hum Genet. 2006 Aug;14(8):904-10
pubmed: 16724007
FEBS Lett. 2006 Aug 7;580(18):4544-50
pubmed: 16870177
J Invest Dermatol. 2007 May;127(5):1175-86
pubmed: 17159913
Development. 2007 Jan;134(1):13-8
pubmed: 17164413
Cell Cycle. 2006 Dec;5(23):2805-11
pubmed: 17172858
Cell. 2007 May 4;129(3):523-36
pubmed: 17482546
Oncogene. 2007 Nov 15;26(52):7363-70
pubmed: 17563751
Cell. 2007 Jul 27;130(2):223-33
pubmed: 17662938
Nat Rev Cancer. 2007 Oct;7(10):800-8
pubmed: 17851543
Cancer Res. 2008 Jul 1;68(13):5122-31
pubmed: 18593911
PLoS One. 2008 Jul 23;3(7):e2715
pubmed: 18648642
J Bioenerg Biomembr. 2008 Jun;40(3):183-91
pubmed: 18651212
J Interferon Cytokine Res. 2008 Dec;28(12):725-32
pubmed: 18937546
Mol Cell Biol. 2009 Jul;29(14):3953-63
pubmed: 19451233
PLoS One. 2009 May 20;4(5):e5623
pubmed: 19461998
EMBO J. 2009 Jul 8;28(13):1904-15
pubmed: 19494829
Cell Stem Cell. 2009 Jul 2;5(1):64-75
pubmed: 19570515
Am J Med Genet A. 2009 Sep;149A(9):1942-7
pubmed: 19681108
Nucleic Acids Res. 2009 Oct;37(18):6092-104
pubmed: 19700772
J Biol Chem. 2009 Oct 30;284(44):30574-82
pubmed: 19717565
Cell Death Differ. 2009 Dec;16(12):1582-9
pubmed: 19763140
J Invest Dermatol. 2010 May;130(5):1249-57
pubmed: 20090763
PLoS One. 2010 Jul 14;5(7):e11572
pubmed: 20644729
Dev Cell. 2010 Dec 14;19(6):807-18
pubmed: 21093383
J Clin Invest. 2011 Feb;121(2):809-20
pubmed: 21293058
Cell Stem Cell. 2011 Feb 4;8(2):164-76
pubmed: 21295273
Cancer Res. 2011 Jul 1;71(13):4373-9
pubmed: 21527555
Cancer Res. 2011 May 15;71(10):3688-700
pubmed: 21576089
PLoS One. 2011;6(7):e21877
pubmed: 21789189
EMBO J. 2011 Sep 06;30(20):4261-73
pubmed: 21897369
J Cell Biol. 2011 Sep 19;194(6):825-39
pubmed: 21930775
Cancer Res. 2011 Nov 1;71(21):6867-77
pubmed: 21933882
Development. 2012 Feb;139(4):772-82
pubmed: 22274697
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
J Biol Chem. 2012 Aug 31;287(36):30170-80
pubmed: 22787154
Cancer Microenviron. 2012 Dec;5(3):311-22
pubmed: 22847008
J Cell Physiol. 2013 Apr;228(4):871-8
pubmed: 23018838
Cell Metab. 2012 Oct 3;16(4):511-25
pubmed: 23040072
J Cancer Res Clin Oncol. 2013 Mar;139(3):437-45
pubmed: 23143645
J Biol Chem. 2013 Feb 1;288(5):3275-88
pubmed: 23239884
Cell Stem Cell. 2013 Feb 7;12(2):193-203
pubmed: 23395444
Mol Carcinog. 2014 Sep;53(9):698-710
pubmed: 23475637
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
PLoS One. 2013 May 01;8(5):e62547
pubmed: 23658742
Br J Cancer. 2013 Jun 25;108(12):2419-25
pubmed: 23660942
Cell Death Differ. 2013 Aug;20(8):1080-8
pubmed: 23686138
EMBO J. 2013 Aug 14;32(16):2248-63
pubmed: 23860128
J Clin Invest. 2013 Aug;123(8):3525-38
pubmed: 23867503
Development. 2013 Sep;140(18):3777-86
pubmed: 23924630
J Pathol. 2014 Feb;232(3):356-68
pubmed: 24258200
Cell. 2013 Dec 19;155(7):1639-51
pubmed: 24332913
Development. 2014 Jan;141(1):101-11
pubmed: 24346698
Cell Cycle. 2014;13(5):749-61
pubmed: 24394434
J Clin Invest. 2014 Apr;124(4):1636-45
pubmed: 24590290
Oncotarget. 2014 Apr 15;5(7):1856-68
pubmed: 24732135
EMBO Rep. 2014 Jun;15(6):642-56
pubmed: 24825474
Nature. 2014 Jul 10;511(7508):246-50
pubmed: 24909994
Clin Cancer Res. 2015 Mar 15;21(6):1447-56
pubmed: 25589618
Oncotarget. 2015 Apr 20;6(11):8434-53
pubmed: 25726529
Nat Commun. 2015 Apr 02;6:6411
pubmed: 25832504
Oncogene. 2016 Jan 21;35(3):344-57
pubmed: 25893299
Front Endocrinol (Lausanne). 2015 Apr 28;6:51
pubmed: 25972840
EMBO Rep. 2015 Jul;16(7):863-78
pubmed: 26034101
Oncogene. 2016 Mar 24;35(12):1493-503
pubmed: 26096935
Sci Signal. 2015 Jul 28;8(387):re9
pubmed: 26221054
Proc Natl Acad Sci U S A. 2015 Sep 15;112(37):11577-82
pubmed: 26324887
Genome Biol. 2015 Dec 18;16:284
pubmed: 26683334
Cancers (Basel). 2015 Dec 09;7(4):2397-414
pubmed: 26690220
Cell Rep. 2016 Mar 15;14(10):2289-300
pubmed: 26947080
Cancer Res. 2016 Jun 1;76(11):3236-51
pubmed: 26988989
Cancer Cell. 2016 May 9;29(5):622-637
pubmed: 27165741
Mol Cell Oncol. 2014 Dec 31;1(4):e969136
pubmed: 27308370
J Invest Dermatol. 2017 Jan;137(1):31-37
pubmed: 27638386
Proc Natl Acad Sci U S A. 2016 Oct 11;113(41):E6107-E6116
pubmed: 27681615
J Invest Dermatol. 2017 Feb;137(2):494-505
pubmed: 27725202
Cancer Res. 2016 Dec 15;76(24):7265-7276
pubmed: 27780825
Oral Dis. 2017 Mar;23(2):247-254
pubmed: 27783844
Oncotarget. 2017 Feb 7;8(6):10726-10740
pubmed: 27802187
Cell Stem Cell. 2017 Feb 2;20(2):191-204.e5
pubmed: 27889319
Oncotarget. 2017 Jan 10;8(2):2114-2129
pubmed: 27924063
Cancer Cell. 2017 Jan 9;31(1):35-49
pubmed: 28041841
J Invest Dermatol. 2017 Jun;137(6):1267-1276
pubmed: 28108301
J Invest Dermatol. 2017 Feb;137(2):280-281
pubmed: 28110711
Cytokine. 2017 Aug;96:114-122
pubmed: 28391028
Arch Oral Biol. 2017 Oct;82:160-165
pubmed: 28645102
Cell Mol Life Sci. 2018 Apr;75(7):1179-1190
pubmed: 29103147
Proc Natl Acad Sci U S A. 2017 Dec 12;114(50):13254-13259
pubmed: 29162693
EMBO Rep. 2018 Jan;19(1):73-88
pubmed: 29217659
EMBO Rep. 2018 Jan;19(1):3-4
pubmed: 29254932
Steroids. 2018 May;133:93-95
pubmed: 29317255
Genes Dev. 2018 Jan 15;32(2):181-193
pubmed: 29440247
Cell Rep. 2018 Apr 3;23(1):194-212.e6
pubmed: 29617660
J Mol Biol. 2018 Jun 22;430(13):1829-1838
pubmed: 29733853
Proc Natl Acad Sci U S A. 2018 May 22;115(21):E4806-E4814
pubmed: 29735662
Clin Cancer Res. 2018 Aug 15;24(16):3917-3927
pubmed: 29739791
Nat Commun. 2018 Sep 6;9(1):3619
pubmed: 30190462
J Clin Invest. 2018 Nov 1;128(11):5095-5109
pubmed: 30295647
Sci Signal. 2018 Oct 09;11(551):
pubmed: 30301786
Oncogene. 2019 Mar;38(10):1625-1638
pubmed: 30337687
Eur J Dermatol. 2018 Oct 1;28(5):597-605
pubmed: 30530431
Cell Rep. 2018 Dec 18;25(12):3490-3503.e4
pubmed: 30566872
Biochem Biophys Res Commun. 2019 Feb 12;509(3):784-789
pubmed: 30635119
Cell Stem Cell. 2019 Feb 7;24(2):271-284.e8
pubmed: 30686763
Am J Med Genet A. 2019 Mar;179(3):442-447
pubmed: 30703280
J Invest Dermatol. 2019 Aug;139(8):1658-1671.e8
pubmed: 30710576
J Cell Biol. 1996 Dec;135(6 Pt 2):1879-87
pubmed: 8991098
Cell. 1997 Aug 22;90(4):809-19
pubmed: 9288759
Mol Cell. 1998 Sep;2(3):305-16
pubmed: 9774969

Auteurs

Michael A Moses (MA)

Laboratory of Molecular Oncology, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.

Andrea L George (AL)

Laboratory of Molecular Oncology, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.
ORCID: 0000-0002-4112-8639

Nozomi Sakakibara (N)

Laboratory of Molecular Oncology, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.

Kanwal Mahmood (K)

Laboratory of Molecular Oncology, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.

Roshini M Ponnamperuma (RM)

Laboratory of Molecular Oncology, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.

Kathryn E King (KE)

Laboratory of Molecular Oncology, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.

Wendy C Weinberg (WC)

Laboratory of Molecular Oncology, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA. wendy.weinberg@fda.hhs.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Tumeurs épithéliales épidermoïdes et glandulaires › Tumeurs épidermoïdes › Carcinome épidermoïde › Molecular Mechanisms of p63-Mediated Squamous...
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Adhérence cellulaire › Molecular Mechanisms of p63-Mediated Squamous...
questionsmedicales.fr › Phénomènes physiologiques des appareils urinaire et reproducteur › Phénomènes physiologiques de la reproduction › Reproduction › Développement embryonnaire et foetal › Développement embryonnaire › Lignage cellulaire › Molecular Mechanisms of p63-Mediated Squamous...
questionsmedicales.fr › Phénomènes physiologiques › Mouvement cellulaire › Molecular Mechanisms of p63-Mediated Squamous...
questionsmedicales.fr › Phénomènes physiologiques › Croissance et développement › Croissance › Processus de croissance cellulaire › Prolifération cellulaire › Molecular Mechanisms of p63-Mediated Squamous...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Processus néoplasiques › Carcinogenèse › Transformation cellulaire néoplasique › Molecular Mechanisms of p63-Mediated Squamous...
questionsmedicales.fr › Système tégumentaire › Peau › Épiderme › Molecular Mechanisms of p63-Mediated Squamous...
questionsmedicales.fr › Cellules › Cellules épithéliales › Molecular Mechanisms of p63-Mediated Squamous...
questionsmedicales.fr › Phénomènes génétiques › Régulation de l'expression des gènes › Régulation de l'expression des gènes tumoraux › Molecular Mechanisms of p63-Mediated Squamous...
questionsmedicales.fr › Tumeurs › Tumeurs par siège › Tumeurs de la tête et du cou › Molecular Mechanisms of p63-Mediated Squamous...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Molecular Mechanisms of p63-Mediated Squamous...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Tumeurs de l'appareil respiratoire › Tumeurs du poumon › Molecular Mechanisms of p63-Mediated Squamous...
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Transduction du signal › Molecular Mechanisms of p63-Mediated Squamous...
questionsmedicales.fr › Maladies de la peau et du tissu conjonctif › Maladies de la peau › Tumeurs cutanées › Molecular Mechanisms of p63-Mediated Squamous...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Facteurs de transcription › Molecular Mechanisms of p63-Mediated Squamous...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines tumorales › Protéines suppresseurs de tumeurs › Molecular Mechanisms of p63-Mediated Squamous...